←
Wittrup Lab72 posts
Wittrup Lab avatar

Wittrup Lab

@TheWittrupLab

The Wittrup lab at the @kochinstitute @MIT. Protein engineering for cancer immunotherapy. Run by lab members @MITChemE @MITdeptofBE

◷ Joined January 2022▧ 6 Photos and videos
rcsb pdb 💉🧬💻🔬💊🌱🧠🦠 avatar
⟳ Wittrup Lab retweeted
rcsb pdb 💉🧬💻🔬💊🌱🧠🦠@buildmodels·6 Jul 2024

How AI Revolutionized Protein Science, but Didn’t End It 3 years ago, Google’s AlphaFold pulled off the biggest artificial intelligence breakthrough in science to date, accelerating molecular research and kindling deep questions about why we do science. quantamagazine.org/how-ai-re…

ACIR avatar
⟳ Wittrup Lab retweeted
ACIR@ACIR_org·28 Mar 2024

Palmeri et al. fused an agonistic anti-4-1BB Ab and the collagen-binding domain of LAIR1 (ɑ4-1BB-LAIR). However, treating mouse tumor models with ɑ4-1BB-LAIR i.t. plus an Ab specific for tumor-expressed antigen [...] bit.ly/4ackehO  @josephrpalmeri  @theWittrupLab

Post attachment
Luciano Santollani avatar
⟳ Wittrup Lab retweeted
Luciano Santollani@LSantollani·4 Jan 2024

Kicking off 2024 by sharing a preprint of my PhD work! We report an engineered cytokine therapy that elicits some of the most profound anti-tumor immunity we have seen in our labs' preclinical work. Preprint and walk-through below:

Local delivery of cell surface-targeted immunocytokines programs systemic anti-tumor immunity biorxiv.org/cgi/content/shor… #biorxiv_immuno

Wittrup Lab avatar
Wittrup Lab@TheWittrupLab·4 Nov 2023

Curious what we’ve been up to recently? Check out our posters at #SITC23 today to learn about collagen anchored cytokine therapy in canines (1094) and how Tregs constrain responses to collagen anchored anti-4-1BB agonist antibody therapy (1224)!

ACIR avatar
⟳ Wittrup Lab retweeted
ACIR@ACIR_org·24 Apr 2023

SPOTLIGHT: To improve the therapeutic window of IL-2 and IL-12, @MIT evaluated canine-ized collagen-binding IL-2 and IL-12 in pet beagles with spontaneous soft tissue sarcomas 👉 https://t.co/VjtfWLREQv

Post attachment
Koch Institute at MIT avatar
⟳ Wittrup Lab retweeted
Koch Institute at MIT@kochinstitute·11 Apr 2023

"I think that back and forth between the industry and the clinical settings and open communication helps to find the next boundary that we can push." Watch the video of our latest with/in/sight, "Anchor Management." youtu.be/lJmLu7lB8zM

By anchoring powerful anti-cancer immunotherapies to tumors, KI engineers found a way that could minimize their very serious toxic side effects. But how are they working to transform this lab discovery into a clinical treatment? Join us Tue, April 4: https://t.co/xypnI3sjyM

Joseph Palmeri avatar
⟳ Wittrup Lab retweeted
Joseph Palmeri@josephrpalmeri·21 Mar 2023

Successfully defended my PhD in chemical engineering from @MIT last week. Wouldn’t have made it through this journey without the endless support of my colleagues in @TheWittrupLab and all of my friends and family. Excited for the next adventure!

Post attachmentPost attachmentPost attachmentPost attachment
Koch Institute at MIT avatar
⟳ Wittrup Lab retweeted
Koch Institute at MIT@kochinstitute·13 Mar 2023

Join Koch Institute immune engineers and @ankyratx CEO Howard Kaufman on April 4 to hear how they are taking anchored immunotherapy against solid tumors from the lab bench to the cancer clinic. Register: https://t.co/xypnI3sRok

Post attachment
ACIR avatar
⟳ Wittrup Lab retweeted
ACIR@ACIR_org·3 Mar 2023

SPOTLIGHT: To enhance the effectiveness and safety of stimulatory receptor agonist antibodies, researchers at @MITdeptofBE developed a collagen-targeting 4-1BB agonist Ab and delivered it directly into B16 melanoma tumors along [...] ow.ly/EjR650N622g

Post attachment
Joseph Palmeri avatar
⟳ Wittrup Lab retweeted
Joseph Palmeri@josephrpalmeri·2 Feb 2023

Excited to share my first first author paper and a large part of my PhD work. A quick tweetorial 🧵 (1/13) biorxiv.org/content/10.1101/…